Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant

OBJECTIVES: Biosimilar filgrastim was compared with lenograstim for autologous haematopoietic stem-cell transplant (HSCT) in patients with haematological malignancies. Data from a separate group of sibling donors who underwent allogeneic HSCT are also reported. METHODS: Patients with lymphoma or mul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Hematol
Main Authors: Uddin, Shab, Russell, Pippa, Farrell, Maresa, Davy, Barbara, Taylor, Joe, Agrawal, Samir G.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365052/
https://ncbi.nlm.nih.gov/pubmed/25830013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620714565962
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados